Global EClinical Solutions Market Size

Q: What is the global market size of the eClinical Solutions Market?

Global eClinical Solutions Market size was valued at USD 7.18 billion in 2021 and is poised to grow from USD 8.15 billion in 2022 to USD 22.35 billion by 2030, growing at a CAGR of 13.4% in the forecast period (2023-2030).

eClinical Solutions Market size was valued at USD 7.18 billion in 2019 and is poised to grow from USD 8.15 billion in 2023 to USD 22.35 billion by 2031, growing at a CAGR of 13.4% in the forecast period (2024-2031).

Global eClinical solutions market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Oracle Corporation', 'Medidata Solutions, Inc.', 'Parexel International Corporation', 'Bioclinica, Inc.', 'OmniComm Systems, Inc.', 'ERT Clinical', 'DATATRAK International, Inc.', 'CRF Health', 'Merge Healthcare, Inc.', 'MedNet Solutions, Inc.', 'Bio-Optronics, Inc.', 'eClinicalWorks LLC', 'ArisGlobal LLC', 'OmniComm Systems, Inc.', 'Anju Software, Inc.', 'Veeva Systems, Inc.', 'Dassault Systemes SE', 'IBM Corporation', 'SAS Institute Inc.', 'PRA Health Sciences, Inc.'

In the field of medical research and novel drug treatments, personalised or gene-based disease management is gaining popularity. When compared to currently available alternative therapies or medications, government reimbursement organisations, commercial insurers, and payers frequently request novel drugs with higher therapeutic value and efficacy, resulting in significant market growth.

Clinical Data Management (CDM) is a critical stage in clinical research that results in the generation of high-quality, reliable, and statistically sound data from clinical trials. This significantly shortens the time between drug development and marketing. Integration of the CDMS with clinical randomization, supply management, trial, and patient recruitment solutions is a strong trend driving this segment.

North America dominated the global eClinical solutions market share, accounting for more than 51% of revenue in 2021, and is likely to maintain the dominant position during the forecast period. A growing target population, combined with an increase in the incidence of lifestyle-related diseases like diabetes and cardiac disorders, is expected to propel market growth. Furthermore, the introduction of new products by eClinical solution vendors, as well as an increase in government grants, are influencing the market in the region during the forecasting years.

eClinical Solutions Market size was valued at USD 7.18 billion in 2021 and is poised to grow from USD 8.15 billion in 2022 to USD 22.35 billion by 2030, growing at a CAGR of 13.4% in the forecast period (2023-2030).

Global eClinical solutions market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Oracle Corporation', 'Medidata Solutions, Inc.', 'Parexel International Corporation', 'Bioclinica, Inc.', 'OmniComm Systems, Inc.', 'ERT Clinical', 'DATATRAK International, Inc.', 'CRF Health', 'Merge Healthcare, Inc.', 'MedNet Solutions, Inc.', 'Bio-Optronics, Inc.', 'eClinicalWorks LLC', 'ArisGlobal LLC', 'OmniComm Systems, Inc.', 'Anju Software, Inc.', 'Veeva Systems, Inc.', 'Dassault Systemes SE', 'IBM Corporation', 'SAS Institute Inc.', 'PRA Health Sciences, Inc.'

In the field of medical research and novel drug treatments, personalised or gene-based disease management is gaining popularity. When compared to currently available alternative therapies or medications, government reimbursement organisations, commercial insurers, and payers frequently request novel drugs with higher therapeutic value and efficacy, resulting in significant market growth.

Clinical Data Management (CDM) is a critical stage in clinical research that results in the generation of high-quality, reliable, and statistically sound data from clinical trials. This significantly shortens the time between drug development and marketing. Integration of the CDMS with clinical randomization, supply management, trial, and patient recruitment solutions is a strong trend driving this segment.

North America dominated the global eClinical solutions market share, accounting for more than 51% of revenue in 2021, and is likely to maintain the dominant position during the forecast period. A growing target population, combined with an increase in the incidence of lifestyle-related diseases like diabetes and cardiac disorders, is expected to propel market growth. Furthermore, the introduction of new products by eClinical solution vendors, as well as an increase in government grants, are influencing the market in the region during the forecasting years.

Global eClinical Solutions Market Insights

Global eClinical Solutions Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Global eClinical Solutions Market Insights

Global eClinical Solutions Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of eClinical Solutions Market?

Who are the key vendors in the Global eClinical Solutions Market?

What is the key driver of Global eClinical Solutions Market?

What is the key market trend for Global eClinical Solutions Market?

Which region accounted for the largest share in Global eClinical Solutions Market?